Are you a new member? Sign up now
Login area
| Sign up
close
OXALIPLATINE VIATRIS 5MG/ML - 50mg - 1
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01XA03 | G | Oxaliplatin - 50mg | 6384 | 218855/09 | OXALIPLATINE VIATRIS 5MG/ML | 50mg | 1 | Injectable powder for solution | Infusion | Benta Trading Co s.a.l. | Benta SAL under license from Viatris Santé, France | Lebanon | 4,135,003 L.L | 23.08 | B | 2/5/2024 | 0 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01XA03 | B | Oxaliplatin - 50mg/10ml | 5150 | 23718/06 | ELOXATIN | 50mg/10ml | 1 x 10ml | Injectable concentrated solution | Infusion | Mersaco | Sanofi Aventis Deutschland GmbH | Germany | 4,930,558 L.L | 23.08 | B | Sanofi Aventis | France | 2/5/2024 | 0 |
| L01XA03 | G | Oxaliplatin - 50mg/10ml | 11522 | 20420/1 | OXALIPLATIN EBEWE | 50mg/10ml | 1 x 10ml | Injectable concentrated solution | Infusion | Khalil Fattal & Fils S.A.L. | Ebewe Pharma GesmbH.NFG.KG | Austria | 3,405,297 L.L | 23.08 | B | Sandoz Pharmaceuticals AG | Switzerland | 2/5/2024 | 0 |
| L01XA03 | G | Oxaliplatin - 50mg | 8487 | 99415/1 | OXALIPLATIN MEDAC | 50mg | 1 | Injectable powder for solution | Infusion | Alfamed S.A.L. | Medac Gesellschaft Fur Klinische Spezialpraparate mbH | Germany | 3,440,237 L.L | 23.08 | B | Medac Gesellschaft Fur Klinische Spezialpraparate mbH | Germany | 2/5/2024 | 0 |
| L01XA03 | G | Oxaliplatin - 50mg | 10953 | 137121/1 | OXALIPLATINO GP PHARM | 50mg | 1 | Injectable lyophilised powder for solution | Infusion | Mediterranean Pharmaceutical Company | GP-Pharm, SA | Argentine | 2,957,797 L.L | 23.08 | B | GP-Pharm, SA | Argentine | 2/5/2024 | 0 |
| L01XA03 | G | Oxaliplatin - 50mg | 6325 | 221167/08 | OXALTIE | 50mg | 1 | Injectable lyophilised powder for solution | Infusion | New Europharm | Bioprofarma S.A. | Argentine | 2,957,797 L.L | 23.08 | B | Bioprofarma S.A. | Argentine | 2/5/2024 | 0 |
| L01XA03 | G | Oxaliplatin - 50mg | 10660 | 12821 | OXALTIE | 50mg | 1 | Injectable lyophilised powder | Infusion | New Europharm | Laboratorio Kemex SA | Argentine | 2,957,797 L.L | 23.08 | B | Bioprofarma Bago SA | Argentine | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024